Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JC242 Tablets for Fever in Adults
ChiCTR2600127792Phase 3Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexibuprofen arginine in fever (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Difference in the temperature-time curve within 4 hours after the first administration. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dexibuprofen arginine
03
Conditions
fever
Beyond the preview
Go deeper on ChiCTR2600127792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127792.